Depot‐specific differences and heterogeneity of adipose‐derived stem cells in diet‐induced obesity
Obesity · 2024
DOI: 10.1002/oby.24149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Honglin Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shandong Provincial Hospital, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Obesity, Liraglutide, Intra-Abdominal Fat, Diet, High-Fat. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Obesity is a global health concern. Studying the heterogeneity of adipose‐derived stem cells (ADSCs) plays a pivotal role in understanding metabolic disorders, such as obesity.
Methods
Mass cytometry was used to determine the depot‐specific differences and heterogeneity of ADSCs and their alterations at the single‐cell level in a diet‐induced‐obesity (DIO) model in which mice were treated with liraglutide.
Results
We characterized the relationship among ADSC markers and found that CD26 and CD142 could identify the most representative heterogeneous ADSCs in subcutaneous adipose tissue and visceral adipose tissue. Specifically, CD26 + CD142 − and CD26 + CD142 + ADSCs were exclusive to subcutaneous adipose tissue and visceral adipose tissue, respectively, whereas CD26 − CD142 + ADSCs were present in both. RNA analysis explored the potential functions of these three subgroups. In the visceral adipose tissue of DIO mice, we observed a substantial downregulation of CD26 + CD142 + ADSCs and upregulation of CD26 − CD142 + ADSCs, both of which were mitigated by liraglutide treatment.
Conclusions
Our study highlights the depot‐specific differences and heterogeneity of ADSCs and their alterations under DIO conditions, which can potentially be reversed by liraglutide treatment. This study provides new insights into the identification of more specific ADSC subgroups to explore the etiology of metabolism‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Shandong Provincial Hospital, Shandong University, Jinan, China.
- Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Biostatistics, School of Public Health, Shandong University, Jinan, China.
- Department of Center Laboratory, Shandong Provincial Hospital, Shandong University, Jinan, China.
- Department of Endocrinology, Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
- Department of Endocrinology, University Town hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Qingbo Guan, Xu Hou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, H., Sheng, A., Qi, X., Zhu, L., Wang, G., Zou, Y., Guan, Q., Lu, Y., Tang, H., & Hou, X. (2024). Depot‐specific differences and heterogeneity of adipose‐derived stem cells in diet‐induced obesity. Obesity. https://doi.org/10.1002/oby.24149
Vancouver
Guo H, Sheng A, Qi X, Zhu L, Wang G, Zou Y, et al. Depot‐specific differences and heterogeneity of adipose‐derived stem cells in diet‐induced obesity. Obesity. 2024. doi:10.1002/oby.24149
BibTeX
@article{Guo2024,
author = {Guo, Honglin and Sheng, Ailing and Qi, Xiangyu and Zhu, Lin and Wang, Guanyu and Zou, Yizhou and Guan, Qingbo and Lu, Yuntao and Tang, Hui and Hou, Xu},
title = {Depot‐specific differences and heterogeneity of adipose‐derived stem cells in diet‐induced obesity},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24149}
}
EUVIMED